Advertisement
Screener

IVERIC bio, Inc. Excess Tax Benefit from Share-based Compensation, Operating Activities

IVERIC bio, Inc. Excess Tax Benefit from Share-based Compensation, Operating Activities

IVERIC bio, Inc. reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-05.

Discontinued › Notes › Compensation Related Costs

us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2018-03-05

  • IVERIC bio, Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2014-12-31 was $1.92M.
  • IVERIC bio, Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2014-09-30 was $1.09M.
  • IVERIC bio, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2017 was $0.00.
  • IVERIC bio, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
  • IVERIC bio, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $1.30M, a 69.41% decline from fiscal 2014.
  • IVERIC bio, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $4.26M.
Period endExcess Tax Benefit from Share-based Compensation, Operating Activities 3 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 6 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 9 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 12 month
2017-12-31$0.00
10-K · filed 2018-03-05
2016-12-31$0.00
10-K · filed 2018-03-05
2015-12-31$1.30M
10-K · filed 2018-03-05
2014-12-31$1.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$3.01M
derived: sum of 2 quarters · filed 2017-02-28
$4.26M
10-K · filed 2017-02-28
2014-09-30$1.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$2.33M
10-Q · filed 2015-11-05
2014-06-30$1.24M
10-Q · filed 2015-08-10